Endowave
Pioneering microwave ablation treatment for early stage lung cancer
Pioneering microwave ablation treatment for early stage lung cancer
Endowave aims to revolutionize the treatment of early stage lung cancer with their pioneering microwave ablation technology. Their fully flexible ablation catheter system, designed to navigate through the patient’s airways, offers minimally invasive tumor destruction in a single intervention. Utilizing patented technology, Endowave ensures fast and reliable ablation in lung tissue. Established in 2018 and headquartered in Ireland, this Health Care startup presents an innovative solution to a critical medical need. With their potential to impact the healthcare industry, Endowave stands as an enticing prospect for venture capital investment, positioned to make significant strides in the field of cancer treatment.
There is no investment information
No recent news or press coverage available for Endowave.
We care about your data, and we'd love to use cookies make your experience better.